Your browser doesn't support javascript.
loading
Appetite-regulating hormones-leptin, adiponectin and ghrelin-and the development of prostate cancer: a systematic review and exploratory meta-analysis.
Angel, Charlotte Zoe; Iguacel, Isabel; Mullee, Amy; Guha, Neela; Wasson, Rachel; McKenna, Declan J; Gunter, Marc J; Smelov, Vitaly; Huybrechts, Inge.
Affiliation
  • Angel CZ; International Agency for Research on Cancer. World Health Organization, 150 cours Albert Thomas, 69372, Lyon CEDEX 08, France.
  • Iguacel I; Biomedical Sciences Research Institute, Ulster University, Cromore Road, Coleraine, BT52 1SA, UK.
  • Mullee A; International Agency for Research on Cancer. World Health Organization, 150 cours Albert Thomas, 69372, Lyon CEDEX 08, France.
  • Guha N; Department of Physiatry and Nursing, University of Zaragoza, Calle de Pedro Cerbuna, 12, 50009, Zaragoza, Spain.
  • Wasson R; International Agency for Research on Cancer. World Health Organization, 150 cours Albert Thomas, 69372, Lyon CEDEX 08, France.
  • McKenna DJ; UCD School of Agriculture and Food Science, Institute of Food and Health, University College Dublin, Belfield, Dublin 4, Ireland.
  • Gunter MJ; International Agency for Research on Cancer. World Health Organization, 150 cours Albert Thomas, 69372, Lyon CEDEX 08, France.
  • Smelov V; Office of Environmental Health Hazard Assessment, California Environmental Protection Agency, Oakland, California, USA.
  • Huybrechts I; International Agency for Research on Cancer. World Health Organization, 150 cours Albert Thomas, 69372, Lyon CEDEX 08, France.
Prostate Cancer Prostatic Dis ; 23(1): 11-23, 2020 03.
Article in En | MEDLINE | ID: mdl-31147627
ABSTRACT

BACKGROUND:

Obesity has been proposed as a risk factor for prostate cancer (PCa). In obesity, serum levels of the appetite-regulating hormones-leptin, adiponectin, and ghrelin-become deregulated.

OBJECTIVE:

To explore whether serum levels of appetite-regulating hormones associate with the incidence of PCa, the incidence of advanced disease, or PCa-specific mortality.

METHODS:

PRISMA guidelines were followed. A systematic search for relevant articles published until March 2019 was performed using the databases PubMed, EMBASE, and Web of Science. Observational studies with data on serum levels of leptin, adiponectin, or ghrelin and PCa outcome were included. Meta-analysis was used to combine risk estimates. Meta-relative risks (mRRs) were calculated using random effects models. When available, raw data was pooled. Publication bias was assessed by funnel plot and Begg's test.

RESULTS:

Thirty-five studies were eligible for inclusion. The qualitative analysis indicated that leptin was not consistently associated with any PCa outcome, although several cohorts reported decreased adiponectin levels in men who later developed advanced PCa. Based on the meta-analysis, there was no significant effect of leptin on PCa incidence (mRR = 0.93 (95% CI 0.75-1.16), p = 0.52) or advanced PCa (mRR = 0.90 (95% CI 0.74-1.10), p = 0.30). There were insufficient studies to estimate the mRR of PCa incidence for men with the highest levels of adiponectin. The combined risk of advanced PCa for men with the highest levels of adiponectin was reduced but did not reach significance (mRR = 0.81 (95% CI 0.61-1.08), p = 0.15).

CONCLUSIONS:

The current evidence does not suggest an association between leptin and PCa outcome. However, there may be an inverse association between adiponectin and the incidence of advanced PCa that should be investigated by further studies. Serum ghrelin has not been largely investigated.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Leptin / Disease Susceptibility / Adiponectin / Ghrelin Type of study: Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies / Systematic_reviews Limits: Humans / Male Language: En Journal: Prostate Cancer Prostatic Dis Journal subject: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Year: 2020 Document type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Leptin / Disease Susceptibility / Adiponectin / Ghrelin Type of study: Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies / Systematic_reviews Limits: Humans / Male Language: En Journal: Prostate Cancer Prostatic Dis Journal subject: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Year: 2020 Document type: Article Affiliation country: France